Please Note: This trial is no longer enrolling new participants
A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects with Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)
| Protocol No. | CTO-000425 | Scope | National |
|---|---|---|---|
| Principal Investigator | Hristos Kaimakliotis | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I/II |
